Braun Stacey Associates Inc. Boosts Stake in Leidos Holdings, Inc. $LDOS

Braun Stacey Associates Inc. increased its position in Leidos Holdings, Inc. (NYSE:LDOS) by 9.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 122,970 shares of the aerospace company’s stock after purchasing an additional 10,572 shares during the quarter. Braun Stacey Associates Inc. owned approximately 0.10% of Leidos worth $22,184,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in LDOS. Allianz Asset Management GmbH increased its stake in shares of Leidos by 20.1% during the third quarter. Allianz Asset Management GmbH now owns 339,972 shares of the aerospace company’s stock valued at $64,241,000 after purchasing an additional 56,905 shares in the last quarter. LBP AM SA boosted its position in shares of Leidos by 43.8% in the 3rd quarter. LBP AM SA now owns 63,211 shares of the aerospace company’s stock worth $11,944,000 after purchasing an additional 19,268 shares in the last quarter. Synergy Asset Management LLC grew its stake in shares of Leidos by 100.0% in the 3rd quarter. Synergy Asset Management LLC now owns 233,470 shares of the aerospace company’s stock worth $44,116,000 after buying an additional 116,735 shares during the last quarter. Bank of Nova Scotia grew its stake in shares of Leidos by 1,353.1% in the 2nd quarter. Bank of Nova Scotia now owns 165,003 shares of the aerospace company’s stock worth $26,031,000 after buying an additional 153,648 shares during the last quarter. Finally, United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund increased its position in Leidos by 120.4% during the 3rd quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund now owns 11,900 shares of the aerospace company’s stock valued at $2,249,000 after buying an additional 6,500 shares in the last quarter. 76.12% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Jefferies Financial Group reiterated a “buy” rating and set a $215.00 price objective on shares of Leidos in a research note on Monday, February 23rd. Royal Bank Of Canada reduced their price target on Leidos from $230.00 to $215.00 and set an “outperform” rating for the company in a report on Wednesday, February 18th. Argus raised Leidos to a “strong-buy” rating in a research report on Tuesday, March 31st. Stifel Nicolaus dropped their price target on shares of Leidos from $220.00 to $205.00 and set a “hold” rating on the stock in a research note on Wednesday, February 18th. Finally, Wall Street Zen downgraded shares of Leidos from a “strong-buy” rating to a “hold” rating in a research report on Saturday, February 21st. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $211.00.

Insider Activity at Leidos

In other news, insider Elizabeth A. Porter sold 3,000 shares of the firm’s stock in a transaction dated Tuesday, January 20th. The stock was sold at an average price of $192.21, for a total value of $576,630.00. Following the transaction, the insider owned 38,575 shares of the company’s stock, valued at $7,414,500.75. This trade represents a 7.22% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.96% of the stock is owned by company insiders.

Leidos Stock Performance

Shares of NYSE LDOS opened at $158.64 on Friday. Leidos Holdings, Inc. has a 12-month low of $128.32 and a 12-month high of $205.77. The firm has a market capitalization of $20.01 billion, a price-to-earnings ratio of 14.25, a price-to-earnings-growth ratio of 1.12 and a beta of 0.65. The company has a current ratio of 1.70, a quick ratio of 1.58 and a debt-to-equity ratio of 0.93. The firm has a 50 day moving average of $173.88 and a 200 day moving average of $184.20.

Leidos (NYSE:LDOS) last issued its quarterly earnings results on Tuesday, February 17th. The aerospace company reported $2.76 earnings per share for the quarter, topping the consensus estimate of $2.57 by $0.19. The business had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.31 billion. Leidos had a net margin of 8.43% and a return on equity of 32.95%. The company’s revenue was down 3.6% compared to the same quarter last year. During the same quarter last year, the company posted $2.37 EPS. Leidos has set its FY 2026 guidance at 12.050-12.450 EPS. On average, research analysts anticipate that Leidos Holdings, Inc. will post 10.62 earnings per share for the current year.

Leidos Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Monday, March 16th were given a $0.43 dividend. The ex-dividend date was Monday, March 16th. This represents a $1.72 dividend on an annualized basis and a yield of 1.1%. Leidos’s dividend payout ratio is presently 15.45%.

Leidos Company Profile

Leidos is an American technology and engineering company that provides services and solutions to government and commercial customers, with a strong focus on national security, defense, intelligence, and civil government markets. The company delivers systems integration, engineering, cybersecurity, software development, data analytics, cloud migration and managed IT services, as well as mission support for complex programs. Leidos’ work spans areas such as C4ISR (command, control, communications, computers, intelligence, surveillance and reconnaissance), secure communications, sensors and systems engineering, and health IT solutions for public-sector healthcare programs.

Leidos traces its corporate roots to Science Applications International Corporation (SAIC) and emerged as an independent, publicly traded company following a corporate separation in 2013.